Report Cover

Global IVD Infectious Diseases Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The IVD Infectious Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global IVD Infectious Diseases size is estimated to be USD 19530 million in 2025 from USD 16930 million in 2019, with a change XX% between 2019 and 2020. The global IVD Infectious Diseases market size is expected to grow at a CAGR of 3.6% for the next five years.

Market segmentation
IVD Infectious Diseases market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Immunochemistry
    Molecular Diagnostics

Market segment by Application, can be divided into
    Clinical Laboratories
    Diagnostic Centers

Market segment by players, this report covers
    BD
    BioMerieux
    Abbott
    Quidel
    Gen-Probe
    Abbott
    Danaher
    Sysmex
    Orasure
    Hologic
    Cepheid
    Qiagen
    Roche Diagnostics
    Siemens Healthcare
    Bio-Rad Laboratories

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of IVD Infectious Diseases
    1.2 Classification of IVD Infectious Diseases by Type
        1.2.1 Overview: Global IVD Infectious Diseases Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global IVD Infectious Diseases Revenue Market Share by Type in 2020
        1.2.3 Immunochemistry
        1.2.4 Molecular Diagnostics
    1.3 Global IVD Infectious Diseases Market by Application
        1.3.1 Overview: Global IVD Infectious Diseases Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Clinical Laboratories
        1.3.3 Diagnostic Centers
    1.4 Global IVD Infectious Diseases Market Size & Forecast
    1.5 Global IVD Infectious Diseases Market Size and Forecast by Region
        1.5.1 Global IVD Infectious Diseases Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global IVD Infectious Diseases Market Size by Region, (2016-2021)
        1.5.3 North America IVD Infectious Diseases Market Size and Prospect (2016-2026)
        1.5.4 Europe IVD Infectious Diseases Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific IVD Infectious Diseases Market Size and Prospect (2016-2026)
        1.5.6 South America IVD Infectious Diseases Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa IVD Infectious Diseases Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 IVD Infectious Diseases Market Drivers
        1.6.2 IVD Infectious Diseases Market Restraints
        1.6.3 IVD Infectious Diseases Trends Analysis
2 Company Profiles
    2.1 BD
        2.1.1 BD Details
        2.1.2 BD Major Business
        2.1.3 BD IVD Infectious Diseases Product and Solutions
        2.1.4 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 BD Recent Developments and Future Plans
    2.2 BioMerieux
        2.2.1 BioMerieux Details
        2.2.2 BioMerieux Major Business
        2.2.3 BioMerieux IVD Infectious Diseases Product and Solutions
        2.2.4 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 BioMerieux Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott IVD Infectious Diseases Product and Solutions
        2.3.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 Quidel
        2.4.1 Quidel Details
        2.4.2 Quidel Major Business
        2.4.3 Quidel IVD Infectious Diseases Product and Solutions
        2.4.4 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Quidel Recent Developments and Future Plans
    2.5 Gen-Probe
        2.5.1 Gen-Probe Details
        2.5.2 Gen-Probe Major Business
        2.5.3 Gen-Probe IVD Infectious Diseases Product and Solutions
        2.5.4 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Gen-Probe Recent Developments and Future Plans
    2.6 Abbott
        2.6.1 Abbott Details
        2.6.2 Abbott Major Business
        2.6.3 Abbott IVD Infectious Diseases Product and Solutions
        2.6.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Abbott Recent Developments and Future Plans
    2.7 Danaher
        2.7.1 Danaher Details
        2.7.2 Danaher Major Business
        2.7.3 Danaher IVD Infectious Diseases Product and Solutions
        2.7.4 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Danaher Recent Developments and Future Plans
    2.8 Sysmex
        2.8.1 Sysmex Details
        2.8.2 Sysmex Major Business
        2.8.3 Sysmex IVD Infectious Diseases Product and Solutions
        2.8.4 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Sysmex Recent Developments and Future Plans
    2.9 Orasure
        2.9.1 Orasure Details
        2.9.2 Orasure Major Business
        2.9.3 Orasure IVD Infectious Diseases Product and Solutions
        2.9.4 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Orasure Recent Developments and Future Plans
    2.10 Hologic 
        2.10.1 Hologic Details
        2.10.2 Hologic Major Business
        2.10.3 Hologic IVD Infectious Diseases Product and Solutions
        2.10.4 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Hologic Recent Developments and Future Plans
    2.11 Cepheid
        2.11.1 Cepheid Details
        2.11.2 Cepheid Major Business
        2.11.3 Cepheid IVD Infectious Diseases Product and Solutions
        2.11.4 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Cepheid Recent Developments and Future Plans
    2.12 Qiagen
        2.12.1 Qiagen Details
        2.12.2 Qiagen Major Business
        2.12.3 Qiagen IVD Infectious Diseases Product and Solutions
        2.12.4 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Qiagen Recent Developments and Future Plans
    2.13 Roche Diagnostics
        2.13.1 Roche Diagnostics Details
        2.13.2 Roche Diagnostics Major Business
        2.13.3 Roche Diagnostics IVD Infectious Diseases Product and Solutions
        2.13.4 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Roche Diagnostics Recent Developments and Future Plans
    2.14 Siemens Healthcare
        2.14.1 Siemens Healthcare Details
        2.14.2 Siemens Healthcare Major Business
        2.14.3 Siemens Healthcare IVD Infectious Diseases Product and Solutions
        2.14.4 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Siemens Healthcare Recent Developments and Future Plans
    2.15 Bio-Rad Laboratories
        2.15.1 Bio-Rad Laboratories Details
        2.15.2 Bio-Rad Laboratories Major Business
        2.15.3 Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions
        2.15.4 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global IVD Infectious Diseases Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 5 IVD Infectious Diseases Players Market Share
        3.2.2 Top 10 IVD Infectious Diseases Players Market Share
        3.2.3 Market Competition Trend
    3.3 IVD Infectious Diseases Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global IVD Infectious Diseases Revenue and Market Share by Type (2016-2021)
    4.2 Global IVD Infectious Diseases Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global IVD Infectious Diseases Revenue Market Share by Application (2016-2021)
    5.2 IVD Infectious Diseases Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America IVD Infectious Diseases Revenue by Type (2016-2026)
    6.2 North America IVD Infectious Diseases Revenue by Application (2016-2026)
    6.3 North America IVD Infectious Diseases Market Size by Country
        6.3.1 North America IVD Infectious Diseases Revenue by Country (2016-2026)
        6.3.2 United States IVD Infectious Diseases Market Size and Forecast (2016-2026)
        6.3.3 Canada IVD Infectious Diseases Market Size and Forecast (2016-2026)
        6.3.4 Mexico IVD Infectious Diseases Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe IVD Infectious Diseases Revenue by Type (2016-2026)
    7.2 Europe IVD Infectious Diseases Revenue by Application (2016-2026)
    7.3 Europe IVD Infectious Diseases Market Size by Country
        7.3.1 Europe IVD Infectious Diseases Revenue by Country (2016-2026)
        7.3.2 Germany IVD Infectious Diseases Market Size and Forecast (2016-2026)
        7.3.3 France IVD Infectious Diseases Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom IVD Infectious Diseases Market Size and Forecast (2016-2026)
        7.3.5 Russia IVD Infectious Diseases Market Size and Forecast (2016-2026)
        7.3.6 Italy IVD Infectious Diseases Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific IVD Infectious Diseases Revenue by Type (2016-2026)
    8.2 Asia-Pacific IVD Infectious Diseases Revenue by Application (2016-2026)
    8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region
        8.3.1 Asia-Pacific IVD Infectious Diseases Revenue by Region (2016-2026)
        8.3.2 China IVD Infectious Diseases Market Size and Forecast (2016-2026)
        8.3.3 Japan IVD Infectious Diseases Market Size and Forecast (2016-2026)
        8.3.4 South Korea IVD Infectious Diseases Market Size and Forecast (2016-2026)
        8.3.5 India IVD Infectious Diseases Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia IVD Infectious Diseases Market Size and Forecast (2016-2026)
        8.3.7 Australia IVD Infectious Diseases Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America IVD Infectious Diseases Revenue by Type (2016-2026)
    9.2 South America IVD Infectious Diseases Revenue by Application (2016-2026)
    9.3 South America IVD Infectious Diseases Market Size by Country
        9.3.1 South America IVD Infectious Diseases Revenue by Country (2016-2026)
        9.3.2 Brazil IVD Infectious Diseases Market Size and Forecast (2016-2026)
        9.3.3 Argentina IVD Infectious Diseases Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa IVD Infectious Diseases Revenue by Type (2016-2026)
    10.2 Middle East & Africa IVD Infectious Diseases Revenue by Application (2016-2026)
    10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country
        10.3.1 Middle East & Africa IVD Infectious Diseases Revenue by Country (2016-2026)
        10.3.2 Turkey IVD Infectious Diseases Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia IVD Infectious Diseases Market Size and Forecast (2016-2026)
        10.3.4 UAE IVD Infectious Diseases Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global IVD Infectious Diseases Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global IVD Infectious Diseases Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market IVD Infectious Diseases Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global IVD Infectious Diseases Revenue (USD Million) by Region (2016-2021) Table 5. Global IVD Infectious Diseases Revenue Market Share by Region (2021-2026) Table 6. BD Corporate Information, Head Office, and Major Competitors Table 7. BD Major Business Table 8. BD IVD Infectious Diseases Product and Solutions Table 9. BD IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. BioMerieux Corporate Information, Head Office, and Major Competitors Table 11. BioMerieux Major Business Table 12. BioMerieux IVD Infectious Diseases Product and Solutions Table 13. BioMerieux IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Abbott Corporate Information, Head Office, and Major Competitors Table 15. Abbott Major Business Table 16. Abbott IVD Infectious Diseases Product and Solutions Table 17. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Quidel Corporate Information, Head Office, and Major Competitors Table 19. Quidel Major Business Table 20. Quidel IVD Infectious Diseases Product and Solutions Table 21. Quidel IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Gen-Probe Corporate Information, Head Office, and Major Competitors Table 23. Gen-Probe Major Business Table 24. Gen-Probe IVD Infectious Diseases Product and Solutions Table 25. Gen-Probe IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Abbott Corporate Information, Head Office, and Major Competitors Table 27. Abbott Major Business Table 28. Abbott IVD Infectious Diseases Product and Solutions Table 29. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Danaher Corporate Information, Head Office, and Major Competitors Table 31. Danaher Major Business Table 32. Danaher IVD Infectious Diseases Product and Solutions Table 33. Danaher IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Sysmex Corporate Information, Head Office, and Major Competitors Table 35. Sysmex Major Business Table 36. Sysmex IVD Infectious Diseases Product and Solutions Table 37. Sysmex IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Orasure Corporate Information, Head Office, and Major Competitors Table 39. Orasure Major Business Table 40. Orasure IVD Infectious Diseases Product and Solutions Table 41. Orasure IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Hologic Corporate Information, Head Office, and Major Competitors Table 43. Hologic Major Business Table 44. Hologic IVD Infectious Diseases Product and Solutions Table 45. Hologic IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Cepheid Corporate Information, Head Office, and Major Competitors Table 47. Cepheid Major Business Table 48. Cepheid IVD Infectious Diseases Product and Solutions Table 49. Cepheid IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Qiagen Corporate Information, Head Office, and Major Competitors Table 51. Qiagen Major Business Table 52. Qiagen IVD Infectious Diseases Product and Solutions Table 53. Qiagen IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Roche Diagnostics Corporate Information, Head Office, and Major Competitors Table 55. Roche Diagnostics Major Business Table 56. Roche Diagnostics IVD Infectious Diseases Product and Solutions Table 57. Roche Diagnostics IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Siemens Healthcare Corporate Information, Head Office, and Major Competitors Table 59. Siemens Healthcare Major Business Table 60. Siemens Healthcare IVD Infectious Diseases Product and Solutions Table 61. Siemens Healthcare IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors Table 63. Bio-Rad Laboratories Major Business Table 64. Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions Table 65. Bio-Rad Laboratories IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Global IVD Infectious Diseases Revenue (USD Million) by Players (2019-2021) Table 67. Global IVD Infectious Diseases Revenue Share by Players (2019-2021) Table 68. Breakdown of IVD Infectious Diseases by Company Type (Tier 1, Tier 2 and Tier 3) Table 69. IVD Infectious Diseases Players Head Office, Products and Services Provided Table 70. IVD Infectious Diseases Mergers & Acquisitions in the Past Five Years Table 71. IVD Infectious Diseases New Entrants and Expansion Plans Table 72. Global IVD Infectious Diseases Revenue (USD Million) by Type (2016-2021) Table 73. Global IVD Infectious Diseases Revenue Share by Type (2016-2021) Table 74. Global IVD Infectious Diseases Revenue Forecast by Type (2021-2026) Table 75. Global IVD Infectious Diseases Revenue by Application (2016-2021) Table 76. Global IVD Infectious Diseases Revenue Forecast by Application (2021-2026) Table 77. North America IVD Infectious Diseases Revenue by Type (2016-2021) & (USD Million) Table 78. North America IVD Infectious Diseases Revenue by Type (2021-2026) & (USD Million) Table 79. North America IVD Infectious Diseases Revenue by Application (2016-2021) & (USD Million) Table 80. North America IVD Infectious Diseases Revenue by Application (2021-2026) & (USD Million) Table 81. North America IVD Infectious Diseases Revenue by Country (2016-2021) & (USD Million) Table 82. North America IVD Infectious Diseases Revenue by Country (2021-2026) & (USD Million) Table 83. Europe IVD Infectious Diseases Revenue by Type (2016-2021) & (USD Million) Table 84. Europe IVD Infectious Diseases Revenue by Type (2021-2026) & (USD Million) Table 85. Europe IVD Infectious Diseases Revenue by Application (2016-2021) & (USD Million) Table 86. Europe IVD Infectious Diseases Revenue by Application (2021-2026) & (USD Million) Table 87. Europe IVD Infectious Diseases Revenue by Country (2016-2021) & (USD Million) Table 88. Europe IVD Infectious Diseases Revenue by Country (2021-2026) & (USD Million) Table 89. Asia-Pacific IVD Infectious Diseases Revenue by Type (2016-2021) & (USD Million) Table 90. Asia-Pacific IVD Infectious Diseases Revenue by Type (2021-2026) & (USD Million) Table 91. Asia-Pacific IVD Infectious Diseases Revenue by Application (2016-2021) & (USD Million) Table 92. Asia-Pacific IVD Infectious Diseases Revenue by Application (2021-2026) & (USD Million) Table 93. Asia-Pacific IVD Infectious Diseases Revenue by Region (2016-2021) & (USD Million) Table 94. Asia-Pacific IVD Infectious Diseases Revenue by Region (2021-2026) & (USD Million) Table 95. South America IVD Infectious Diseases Revenue by Type (2016-2021) & (USD Million) Table 96. South America IVD Infectious Diseases Revenue by Type (2021-2026) & (USD Million) Table 97. South America IVD Infectious Diseases Revenue by Application (2016-2021) & (USD Million) Table 98. South America IVD Infectious Diseases Revenue by Application (2021-2026) & (USD Million) Table 99. South America IVD Infectious Diseases Revenue by Country (2016-2021) & (USD Million) Table 100. South America IVD Infectious Diseases Revenue by Country (2021-2026) & (USD Million) Table 101. Middle East & Africa IVD Infectious Diseases Revenue by Type (2016-2021) & (USD Million) Table 102. Middle East & Africa IVD Infectious Diseases Revenue by Type (2021-2026) & (USD Million) Table 103. Middle East & Africa IVD Infectious Diseases Revenue by Application (2016-2021) & (USD Million) Table 104. Middle East & Africa IVD Infectious Diseases Revenue by Application (2021-2026) & (USD Million) Table 105. Middle East & Africa IVD Infectious Diseases Revenue by Country (2016-2021) & (USD Million) Table 106. Middle East & Africa IVD Infectious Diseases Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. IVD Infectious Diseases Picture Figure 2. Global IVD Infectious Diseases Revenue Market Share by Type in 2020 Figure 3. Immunochemistry Figure 4. Molecular Diagnostics Figure 5. IVD Infectious Diseases Revenue Market Share by Application in 2020 Figure 6. Clinical Laboratories Picture Figure 7. Diagnostic Centers Picture Figure 8. Global IVD Infectious Diseases Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 9. Global IVD Infectious Diseases Revenue and Forecast (2016-2026) & (USD Million) Figure 10. Global IVD Infectious Diseases Revenue Market Share by Region (2016-2026) Figure 11. Global IVD Infectious Diseases Revenue Market Share by Region in 2020 Figure 12. North America IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026) Figure 13. Europe IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026) Figure 14. Asia-Pacific IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026) Figure 15. South America IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. IVD Infectious Diseases Market Drivers Figure 17. IVD Infectious Diseases Market Restraints Figure 18. IVD Infectious Diseases Market Trends Figure 19. BD Recent Developments and Future Plans Figure 20. BioMerieux Recent Developments and Future Plans Figure 21. Abbott Recent Developments and Future Plans Figure 22. Quidel Recent Developments and Future Plans Figure 23. Gen-Probe Recent Developments and Future Plans Figure 24. Abbott Recent Developments and Future Plans Figure 25. Danaher Recent Developments and Future Plans Figure 26. Sysmex Recent Developments and Future Plans Figure 27. Orasure Recent Developments and Future Plans Figure 28. Hologic Recent Developments and Future Plans Figure 29. Cepheid Recent Developments and Future Plans Figure 30. Qiagen Recent Developments and Future Plans Figure 31. Roche Diagnostics Recent Developments and Future Plans Figure 32. Siemens Healthcare Recent Developments and Future Plans Figure 33. Bio-Rad Laboratories Recent Developments and Future Plans Figure 35. Global IVD Infectious Diseases Revenue Share by Players in 2020 Figure 36. IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 37. Global Top 3 Players IVD Infectious Diseases Revenue Market Share in 2020 Figure 38. Global Top 10 Players IVD Infectious Diseases Revenue Market Share in 2020 Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 40. Global IVD Infectious Diseases Revenue Share by Type in 2020 Figure 41. Global IVD Infectious Diseases Market Share Forecast by Type (2021-2026) Figure 42. Global IVD Infectious Diseases Revenue Share by Application in 2020 Figure 43. Global IVD Infectious Diseases Market Share Forecast by Application (2021-2026) Figure 44. North America IVD Infectious Diseases Sales Market Share by Type (2016-2026) Figure 45. North America IVD Infectious Diseases Sales Market Share by Application (2016-2026) Figure 46. North America IVD Infectious Diseases Revenue Market Share by Country (2016-2026) Figure 47. United States IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 48. Canada IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. Mexico IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. Europe IVD Infectious Diseases Sales Market Share by Type (2016-2026) Figure 51. Europe IVD Infectious Diseases Sales Market Share by Application (2016-2026) Figure 52. Europe IVD Infectious Diseases Revenue Market Share by Country (2016-2026) Figure 53. Germany IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 54. France IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 55. United Kingdom IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 56. Russia IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. Italy IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Asia-Pacific IVD Infectious Diseases Sales Market Share by Type (2016-2026) Figure 59. Asia-Pacific IVD Infectious Diseases Sales Market Share by Application (2016-2026) Figure 60. Asia-Pacific IVD Infectious Diseases Revenue Market Share by Region (2016-2026) Figure 61. China IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. Japan IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. South Korea IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. India IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Southeast Asia IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Australia IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. South America IVD Infectious Diseases Sales Market Share by Type (2016-2026) Figure 68. South America IVD Infectious Diseases Sales Market Share by Application (2016-2026) Figure 69. South America IVD Infectious Diseases Revenue Market Share by Country (2016-2026) Figure 70. Brazil IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Argentina IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Middle East and Africa IVD Infectious Diseases Sales Market Share by Type (2016-2026) Figure 73. Middle East and Africa IVD Infectious Diseases Sales Market Share by Application (2016-2026) Figure 74. Middle East and Africa IVD Infectious Diseases Revenue Market Share by Country (2016-2026) Figure 75. Turkey IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. Saudi Arabia IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 77. UAE IVD Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Methodology Figure 79. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us